However, pancreatic tumor cells driven by oncogenic KRAS exhibit constitutive NF‐κB activation,[42] suggesting that additional conditions or factors are required for NF‐κB activation in the context of oncogenic KRAS. Here, KRAS is linked to pancreatic neoplasm.